News | Pediatric Imaging | May 06, 2020

Philips Ultrasound Solution for Pediatric Assessment Provides Gentler Approach

The new transducer reaches a 30% greater penetration, so clinicians have detailed images and performance they need to make a definitive diagnosis for pediatric patients, reducing the need for additional diagnostic imaging steps

The new transducer reaches a 30% greater penetration, so clinicians have detailed images and performance they need to make a definitive diagnosis for pediatric patients, reducing the need for additional diagnostic imaging steps

May 6, 2020 — Philips announced the ultimate ultrasound solution for pediatric assessment, the latest addition for its Philips Ultrasound System (EPIQ Elite). The new ultrasound solution provides clinicians with exceptionally detailed images and the performance they need to make a definitive diagnosis for pediatric patients, reducing the need for additional diagnostic imaging steps, such as X-ray imaging.

The new ultrasound solution from Philips is designed specifically for pediatric clinical use. It combines dedicated transducers, enhanced processing, and software tools that are optimized for the pediatric diagnostic workflow to help improve the experience of both young patients and staff. Children are more radiosensitive than adults, and efforts should be made to minimize risk by reducing unnecessary exposure to radiation [1]. So, a more gentle form of medical imaging is recommended when there is a clear indication for use.

“The new pediatric assessment solution on the EPIQ Elite system has elevated our ultrasound practice at Phoenix Children’s,” said Luis Goncalves, M.D., pediatric radiologist at Phoenix Children’s Hospital. “In particular, the solution’s new transducer offers exceptional clinical performance and versatility across many pediatric applications. For example, the intracranial detail we see in the neonatal head is truly exceptional.”

Pediatric patients come in all shapes and sizes. From the tiniest premature newborn baby to adult-sized pediatric patients, Philips offers a complete imaging solution to elevate diagnostic confidence in even the most challenging cases. The Philips ultimate ultrasound solution for pediatric assessment includes a new pediatric transducer, offering a 30% greater penetration [2] for more detailed images, and has a tailored pediatric workflow to help clinicians diagnose pediatric patients more quickly.

“Diagnostic confidence is vital for any clinician, especially when diagnosing the most sensitive patients,” said Jeff Cohen, vice president, and general manager General Imaging Ultrasound at Philips. “Philips ultimate ultrasound solutions provide the right level of image detail and context that clinicians need to make a precise diagnosis.”

The Philips ultimate ultrasound solution for pediatric assessment is cleared for pediatric clinical use. It extends Philips’ portfolio of dedicated solutions on the Philips Ultrasound System (EPIQ Elite) tailored to the needs of particular medical specialties. Ultrasound solutions for clinical use from Philips are available for the assessment of Small PartsLiverVascularBreast, and now Pediatrics.

 

Availability

Philips ultimate ultrasound solution for pediatric assessment and the Ultrasound System (EPIQ Elite) update are available globally [3].

[1] www.fda.gov/radiation-emitting-products/medical-imaging/pediatric-x-ray-imaging

[2] The new mC12-3 pediatric transducer offers 30% greater penetration in comparison to the previous generation

[3] Worldwide availability, excluding China and few other countries

Related Content

Guerbet announced the launch of OptiProtect 3S, a new range of technical services for its injection solutions. OptiProtect 3S is designed to support imaging centers in the daily use and protection of their injection solutions.
News | Contrast Media Injectors | February 25, 2021
February 25, 2021 — Guerbet announced the launch of ...
An example of cardiac ultrasound longitudinal strain measurements on the Epsilon EchoInsight software. This can be used to assess cardiotoxicity from chemotherapy agents. 

An example of cardiac ultrasound longitudinal strain measurements on the Epsilon EchoInsight software. This can be used to assess cardiotoxicity from chemotherapy agents. 

News | Cardio-oncology | February 25, 2021
February 25, 2020 — Results of a multi-centre, international, clinical trial co-led by Peter Munk Cardiac Centre (PMC
GE Healthcare introduced its artificial intelligence (AI) automation features on its Voluson Swift ultrasound platform at the 2020 Radiological Society of North America (RSNA) virtual meeting. Features of this system include semi-automated contouring, auto identification of fetal anatomy and positioning on imaging. AI is seeing increasing integration in ultrasound systems from numerous vendors.

GE Healthcare introduced its artificial intelligence (AI) automation features on its Voluson Swift ultrasound platform at the 2020 Radiological Society of North America (RSNA) virtual meeting. Features of this system include semi-automated contouring, auto identification of fetal anatomy and positioning on imaging. AI is seeing increasing integration in ultrasound systems from numerous vendors.

Feature | Ultrasound Imaging | February 18, 2021 | By Dave Fornell, Editor
Recent advances in ultrasound image sy...
Example MR images from paediatric brain tumour patients. This first column shows T1-weighted images following the injection of gadolinium contrast agent. The second column shows T2-weighted images and the final column shows apparent diffusion coefficient maps calculated from diffusion-weighted images. (a–c) are taken from a patient with a Pilocytic Astrocytoma, (d–f) are from a patient with an Ependymoma and (g–i) were acquired from a patient with a Medulloblastoma.

Example MR images from paediatric brain tumour patients. This first column shows T1-weighted images following the injection of gadolinium contrast agent. The second column shows T2-weighted images and the final column shows apparent diffusion coefficient maps calculated from diffusion-weighted images. (ac) are taken from a patient with a Pilocytic Astrocytoma, (df) are from a patient with an Ependymoma and (gi) were acquired from a patient with a Medulloblastoma. Image courtesy of Nature Research Journal

News | Pediatric Imaging | February 17, 2021
February 17, 2021 — Diffusio...
Insightec plans to expand in Latin America through a partnership with Strattner
News | Focused Ultrasound Therapy | February 16, 2021
February 16, 2021 — Insightec, a global healthcare company focused on creating the next generation of patient care, a
Brazilian researchers found that the higher the lung ultrasound score the greater the risk of ICU admission, intubation and death. Image courtesy of Julio Alencar

Brazilian researchers found that the higher the lung ultrasound score the greater the risk of ICU admission, intubation and death. Image courtesy of Julio Alencar

News | Coronavirus (COVID-19) | February 11, 2021
February 11, 2021 — ...
Comparison of breast cancer mortality rates (red squares) and distant-stage breast cancer incidence rates from SEER9 (blue dots) and SEER18 (green dots) per 100,000 for white women aged, A, 20–39, B, 40–69, and, C, 70–79 years (3,7,8).

Comparison of breast cancer mortality rates (red squares) and distant-stage breast cancer incidence rates from SEER9 (blue dots) and SEER18 (green dots) per 100,000 for white women aged, A, 20–39, B, 40–69, and, C, 70–79 years (3,7,8). Image courtesy of Radiology 

News | Breast Imaging | February 10, 2021
February 10, 2021 — Breast cancer death rates have stopped declining for women in the U.S.

Images in 69-year-old man with biopsy-confirmed Gleason score 7 (3+4) prostate cancer. (a) Pretreatment axial T2-weighted fast spin-echo MRI scan (repetition time msec/echo time msec, 3820/97) shows tumor in midline anterior transition zone (arrow). (b) Intraoperative MRI scan shows contoured rectal wall (red line), prostate margin (blue outline), and region of interest (orange outline). Because the urethra was included in planned treatment volume, a suprapubic catheter was placed for continuous bladder drainage during treatment. (c) Intraoperative MRI scan shows focused ultrasound beam path (blue) overlaid on treatment plan. Rectangles illustrate each sonication spot. (d) Thermal map image obtained during treatment with heat deposition color coded in red overlaid on sonication spot. (e) Axial gadopentetate dimeglumine-enhanced MRI scan (230/2.97) obtained immediately after treatment shows devascularized ablated volume (arrows). (f) Corresponding T2-weighted fast spin-echo MRI scan (3820/97) at 5 months after ablation shows complete involution of transition zone. All seven cores from treatment area margins were negative for cancer at biopsy. Image courtesy of the Radiological Society of North America

News | Prostate Cancer | February 05, 2021
February 5, 2021 — A technique that delivers...